A model for the resistance of tumor cells to cancer chemotherapeutic agents

From MaRDI portal
Revision as of 23:19, 30 January 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:1055358

DOI10.1016/0025-5564(83)90066-4zbMath0519.92008OpenAlexW1976915041MaRDI QIDQ1055358

James H. Goldie, Andrew J. Coldman

Publication date: 1983

Published in: Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/0025-5564(83)90066-4




Related Items (47)

The transient solution of the linear birth-death process with random spontaneous mutationOptimal drug regimens in cancer chemotherapy for single drugs that block progression through the cell cycleOptimal control of a mathematical model for cancer chemotherapy under tumor heterogeneityChemotherapeutic treatments: A study of the interplay among drug resistance, toxicity and recuperation from side effectsConflicting objectives in chemotherapy with drug resistanceOptimal control of cancer chemotherapy with delays and state constraintsOptimal therapy scheduling based on a pair of collaterally sensitive drugsImpact of resistance on therapeutic design: a Moran model of cancer growthStochastic modeling of drug resistance in cancerModeling the dynamics of heterogeneity of solid tumors in response to chemotherapyOptimal control problems for differential equations applied to tumor growth: state of the artExtinction models for cancer stem cell therapyThe effect of heterogeneity on optimal regimens in cancer chemotherapyOptimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer modelRole of optimal control theory in cancer chemotherapyThe worst drug rule revisited: mathematical modeling of cyclic cancer treatmentsIndividual-based approaches to birth and death in avascular tumorsModelling growth of drug resistant cancer populations as a system with positive feedbackA survey of optimization models on cancer chemotherapy treatment planningStochastic modeling of cellular colonies with quiescence: an application to drug resistance in cancerOptimizing multi-modal cancer treatment under 3D spatio-temporal tumor growthOptimal control of tumor size used to maximize survival time when cells are resistant to chemotherapyLow-intensity combination chemotherapy maximizes host survival time for tumors containing drug-resistant cellsThe fixed-size Luria-Delbrück model with a nonzero death rateModeling the chemotherapy-induced selection of drug-resistant traits during tumor growthA mathematical model of the P-glycoprotein pump as a mediator of multidrug resistanceOn the probability of random genetic mutations for various types of tumor growthThe impact of cell density and mutations in a model of multidrug resistance in solid tumorsMultistage carcinogenesis and the fraction at riskAn alternative approach to modelling relapse in cancer with an application to adenocarcinoma of the prostateDistributed parameters deterministic model for treatment of brain tumors using Galerkin finite element methodA mixed model of carcinogenesis with applications to retinoblastomaMaximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancersDrug kinetics and drug resistance in optimal chemotherapyChemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicityCancer chemotherapy with immunostimulation: A nonhomogeneous stochastic model for drug resistance. I: One drug caseNumerical simulation of a stochastic model for cancerous cells submitted to chemotherapyModeling continuous levels of resistance to multidrug therapy in cancerA stochastic model for the origin and treatment of tumors containing drug-resistant cellsОпухолевый рост и возможности математического моделирования системных процессовOn the role of tumor heterogeneity for optimal cancer chemotherapyA 3-compartment model for chemotherapy of heterogeneous tumor populationsA cellular automata model of chemotherapy effects on tumour growth: targeting cancer and immune cellsOptimal control for a stochastic model of cancer chemotherapyThe effect of cellular differentiation on the development of permanent drug resistanceA mathematical model for the inhibition of the multidrug resistance- associated \(p\)-glycoprotein pumpModeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors




Cites Work




This page was built for publication: A model for the resistance of tumor cells to cancer chemotherapeutic agents